3-year, labor-hour (LH) type task order for medical writers support services (post-market surveillance) to support the U.S. Food and drug administration (FDA), center for biologics evaluation and…
Active Awarded Last action
- Contract number
- 75F40126F19009
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,855,874
Award facts
- Opportunity
-
- CBER2026135070 Solicitation number
- Contract value 32% obligated
-
- $2,855,873.60 Current, with exercised options
- $8,828,529.66 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a $8.83 million delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 28, 2026, for medical writers support services in post-market surveillance under an 8(a) sole-source set-aside. The order is a three-year labor-hour delivery order with an ultimate completion date of September 27, 2029, and place of performance in Silver Spring, Maryland.
Kaiva Strategies is an 8(a) Business Development Program participant and joint venture entity headquartered in Ivins, Utah. The company operates primarily as a managed service delivery vehicle, with subcontractors performing approximately 70 percent of contractor hours across its SCI-reportable prime contracts. Government-paid rates on Kaiva's prime contracts median around $113.91 per hour, with a range spanning $86.72 to $254.48 per hour. The order supports FDA's Center for Biologics Evaluation and Research, Office of Biostatistics and Pharmacovigilance.
Description
3-year, labor-hour (LH) type task order for medical writers support services (post-market surveillance) to support the U.S. Food and drug administration (FDA), center for biologics evaluation and research (cber), office of biostatistics and pharmacov
Quick answers
Who was awarded contract 75F40126F19009?
75F40126F19009 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 28, 2026.
How much is contract 75F40126F19009 worth?
The government has obligated $2,855,874 on 75F40126F19009. Its potential value, with all options, is $8,828,530.
Is contract 75F40126F19009 an order under another contract?
Yes. 75F40126F19009 is a delivery order under 75F40122D00018, an indefinite delivery contract.
Was contract 75F40126F19009 competed?
The extent of competition for 75F40126F19009 was not available for competition. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award